Assenagon Asset Management’s Pacira BioSciences PCRX Stock Holding History

Assenagon Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.57M	Buy	+101,429	New	+$2.4M	﹤0.01%	805
2026 Q1	–	Sell	-435,143	Closed	-$11.3M	–	1193
2025 Q4	$11.3M	Buy	435,143 +202,773	+87%	+$4.82M	0.02%	488
2025 Q3	$5.99M	Sell	232,370 -250,594	-52%	-$6.16M	0.01%	583
2025 Q2	$11.5M	Sell	482,964 -190,325	-28%	-$4.8M	0.02%	439
2025 Q1	$16.7M	Buy	673,289 +221,196	+49%	+$5.3M	0.03%	353
2024 Q4	$8.52M	Sell	452,093 -101,021	-18%	-$1.77M	0.01%	550
2024 Q3	$8.32M	Buy	553,114 +419,656	+314%	+$7.17M	0.02%	580
2024 Q2	$3.82M	Sell	133,458 -62,837	-32%	-$1.79M	0.01%	710
2024 Q1	$5.74M	Sell	196,295 -50,326	-20%	-$1.55M	0.01%	576
2023 Q4	$8.32M	Buy	246,621 +160,149	+185%	+$4.69M	0.02%	499
2023 Q3	$2.65M	Sell	86,472 -121,415	-58%	-$4.38M	0.01%	758
2023 Q2	$8.33M	Buy	207,887 +56,063	+37%	+$2.32M	0.03%	387
2023 Q1	$6.2M	Buy	+151,824	New	+$6.04M	0.02%	518
2022 Q1	–	Sell	-140,468	Closed	-$8.45M	–	1528
2021 Q4	$8.45M	Buy	140,468 +108,873	+345%	+$6M	0.02%	368
2021 Q3	$1.77M	Sell	31,595 -37,171	-54%	-$2.14M	0.01%	740
2021 Q2	$4.17M	Hold	68,766	–	–	0.01%	526
2021 Q1	$4.82M	Sell	68,766 -5	-0%	-$357	0.02%	519
2020 Q4	$4.12M	Buy	+68,771	New	+$4.03M	0.02%	389
2020 Q3	–	Sell	-73,202	Closed	-$3.84M	–	1301
2020 Q2	$3.84M	Buy	+73,202	New	+$3.06M	0.02%	396

Other funds holding PCRX

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

MAM

Milestone Asset Management Pittsburgh, Pennsylvania $636M AUM 22.1% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Assenagon Asset Management's PCRX Position: Q2 2026 in Review

Assenagon Asset Management opened a new position in Pacira BioSciences (PCRX) in Q2 2026: 101,429 shares worth $2.57M. The stake represents ﹤0.01% of the portfolio and ranks #805 among its holdings. This is a return to the name: Assenagon Asset Management previously reported a position in PCRX as recently as Q4 2025.

Assenagon Asset Management first reported a position in PCRX in Q2 2020 and has held it in 19 quarters since. The position peaked at $16.7M in Q1 2025. 20 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Assenagon Asset Management held 101,429 shares of Pacira BioSciences worth $2.57M as of Q2 2026.
Pacira BioSciences was a new Assenagon Asset Management position in Q2 2026.
Pacira BioSciences made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #805 holding.
Assenagon Asset Management first reported a position in Pacira BioSciences in Q2 2020 and has held it in 19 quarters since.
Assenagon Asset Management's Pacira BioSciences position peaked at $16.7M in Q1 2025.
20 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.